Aptevo Therapeutics (NASDAQ:APVO) Upgraded to Sell at StockNews.com
StockNews.com upgraded shares of Aptevo Therapeutics (NASDAQ:APVO – Free Report) to a sell rating in a research report released on Saturday morning. Aptevo Therapeutics Stock Performance Aptevo Therapeutics stock opened at $2.41 on Friday. The stock’s fifty day moving average price is $3.85 and its two-hundred day moving average price is $171.77. Aptevo Therapeutics has […]
